Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

DexCom Inc., consolidated balance sheet: assets

US$ in thousands

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Cash and cash equivalents 642,300 1,052,600 817,600 446,200 1,137,000
Short-term marketable securities 1,813,900 1,678,600 1,890,100 1,087,100 248,600
Accounts receivable, net 713,300 514,300 428,500 286,300 226,700
Inventory 306,700 357,300 234,700 119,800 70,700
Prepaid expenses 48,900 39,800
Prepaid inventory 67,800 12,100
Income tax receivables 38,900 2,300
Other current assets 37,000 27,400 53,900 30,000 16,500
Prepaid and other current assets 192,600 81,600 53,900 30,000 16,500
Current assets 3,668,800 3,684,400 3,424,800 1,969,400 1,699,500
Property and equipment, net 1,055,600 801,800 515,300 321,300 183,100
Operating lease right-of-use assets 80,000 88,100 93,300 71,500
Goodwill 25,700 26,500 19,300 18,600 18,700
Intangibles, net 173,300 31,500
Deferred tax assets 341,200 220,800 216,400
Other assets 47,100 10,500 21,400 14,200 14,700
Non-current assets 1,722,900 1,179,200 865,700 425,600 216,500
Total assets 5,391,700 4,863,600 4,290,500 2,395,000 1,916,000

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. DexCom Inc. current assets increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. DexCom Inc. property and equipment, net increased from 2020 to 2021 and from 2021 to 2022.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. DexCom Inc. non-current assets increased from 2020 to 2021 and from 2021 to 2022.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. DexCom Inc. total assets increased from 2020 to 2021 and from 2021 to 2022.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. DexCom Inc. cash and cash equivalents increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.
Short-term marketable securities Amount of investment in marketable security, classified as current. DexCom Inc. short-term marketable securities decreased from 2020 to 2021 but then increased from 2021 to 2022 not reaching 2020 level.
Accounts receivable, net Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. DexCom Inc. accounts receivable, net increased from 2020 to 2021 and from 2021 to 2022.
Inventory Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. DexCom Inc. inventory increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.